Enanta Pharmaceuticals Inc (ENTA)
R&D Expense Growth
13.80%
Quarterly · Period ending:
ENTA R&D Expense Growth
Latest reported13.80%period ending
Latest reported13.80%period ending
ENTA Quarterly R&D Growth (QoQ) (0.00% → 13.80%)
Latest values, visible window
High-resolution chart · PNG
ENTA r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 13.7993% | |
| -6.7884% | |
| -12.3903% | |
| -12.4991% | |
| -3.0465% | |
| 1.4789% | |
| -10.1436% | |
| 7.0837% | |
| -19.23% | |
| -2.1611% | |
| 0.5641% | |
| -15.8653% | |
| -1.1066% | |
| 6.2735% | |
| 17.548% | |
| -10.9849% | |
| -7.121% | |
| -13.3103% | |
| -0.8111% | |
| 4.1537% | |
| 13.2222% | |
| 13.2033% | |
| -0.0572% | |
| 5.7782% | |
| 6.3539% | |
| -0.5125% | |
| -15.3439% | |
| 12.356% | |
| 0.8959% | |
| -2.0729% | |
| 29.5472% | |
| -5.4902% | |
| 32.5964% | |
| 19.6081% | |
| 8.7683% | |
| 7.185% | |
| 18.4789% | |
| 3.8161% | |
| 8.9217% | |
| 6.6296% | |
| 17.9591% | |
| 1.2178% | |
| 28.1458% | |
| 12.7299% | |
| 16.4866% | |
| 18.7873% | |
| -13.1296% | |
| 14.2543% | |
| -3.579% | |
| 10.7671% | |
| -0.8605% | |
| 6.462% | |
| 4.773% | |
| -19.654% | |
| 12.7615% | |
| -13.6041% | |
| 50.9347% | |
| 22.1183% | |
| -8.7743% | |
| 0% |